Last Week’s Top 3 Most Read Posts on Pulmonary Hypertension

by Marta Ribeiro | January 11, 2016

Read the articles here:

1. PAH Drug Associated with Fewer Deaths, Disease Complications in Phase 3 Study

2. New PAH Drug from Actelion Approved by FDA

3. Reata PH Study Expands to Include Patients with Interstitial Lung Disease

Print This Page

About the Author

Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.